Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -3.74
- Piotroski Score 2.00
- Grade Neutral
- Symbol (RAIN)
- Company Rain Therapeutics Inc.
- Price $1.21
- Changes Percentage (-1.63%)
- Change -$0.02
- Day Low $1.21
- Day High $1.27
- Year High $11.32
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinical trial for intimal sarcoma, as well as RAD52 which is in preclinical trials for tumors, including breast, ovarian, pancreatic, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$2.07
- Trailing P/E Ratio -0.58454106280193
- Forward P/E Ratio -0.58454106280193
- P/E Growth -0.58454106280193
- Net Income $-75,724,000
Income Statement
Quarterly
Annual
Latest News of RAIN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Oil heads for weekly gains on anxiety over intensifying Ukraine war
By Florence Tan(Reuters) -Oil prices extended gains on Friday, heading for a weekly uptick of more than 4%, as the Ukraine war intensified with Russian President Vladimir Putin warning of a global con...
By Reuters | 4 hours ago -
3 No-Brainer Energy Stocks to Buy With $1,000 Right Now
The U.S. faces a significant increase in power demand due to various factors like electrification, electric vehicles, and data centers. Companies like Kinder Morgan and Williams are key players in the...
By Yahoo! Finance | 23 hours ago -
Rain, Finally. But We Need a Lot More.
New York faces a severe drought, eagerly anticipating a much-needed downpour today. The city and upstate areas are in dire need of rain to combat the dry conditions and low reservoir levels. Despite t...
By The New York Times | 1 day ago
